ATA Management of Patients with Anaplastic Thyroid Cancer Guideline Summary - Guideline Central
Diagnosis
Treatment
Document Overview

Management of Patients with Anaplastic Thyroid Cancer

American Thyroid Association


Publication Date: Mar 20, 2021

Page Last Updated: Feb 5, 2026


ATA Grading System


Document Overview

Document Title
Management of Patients with Anaplastic Thyroid Cancer
Authoring Society

American Thyroid Association

Document Publication Date
Mar 20, 2021
Page Last Reviewed/Updated
Feb 5, 2026
Document Type
Guideline
Country of Publication
United States
Full Text Freely Available
Yes
Full Text Guideline
www.liebertpub.com/doi/10.1089/thy.2020.0944
Source Citation

Bible KC, Kebebew E, Brierley JD, et al. American Thyroid Association Anaplastic Thyroid Cancer Guidelines Task Force. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid 2021;31(3):337-386


Document Scope, Criteria, and Use Cases

Document Objectives

Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid cancer. Since the guidelines for the management of ATC by the American Thyroid Association were first published in 2012, significant clinical and scientific advances have occurred in the field. The aim of these guidelines is to inform clinicians, patients, and researchers on published evidence relating to the diagnosis and management of ATC.

Scope
Assessment and Screening, Counseling, Diagnosis, Management, Treatment
Diseases/Conditions (MeSH)

D065646 - Thyroid Carcinoma, Anaplastic

Keywords
anaplastic thyroid cancer
Target Patient Population
patients with anaplastic thyroid cancer (ATC)
Health Care Settings
Ambulatory, Hospital, Outpatient, Radiology Services
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Number of Source Documents
330
Literature Search Start Date
Wednesday, February 15, 2017
Literature Search End Date
Monday, May 11, 2020
Includes peer/external review process?
Yes
Includes public comment process?
No
Methodologist involvement?
Yes
Patient involvement?
No
Includes multi-disciplinary group?
Yes
Includes systematic review?
Yes
Grades quality of strength of evidence?
Yes
Grades quality of strength of recommendation?
Yes
Discloses funding source?
No
Discloses conflicts of interest?
No
Includes benefits/harms analysis with recommendations?
Yes
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.